Polaprezinc prevents ongoing thioacetamide-induced liver fibrosis in rats

Life Sciences

Volumn 90, Issue 3-4, 2012, Pages 122-130

  Kono, Toru ^a   Asama, Toshiyuki ^a   Chisato, Naoyuki ^a   Ebisawa, Yoshiaki ^a   Okayama, Taishi ^a   Imai, Kouji ^a   Karasaki, Hidenori ^a   Furukawa, Hiroyuki ^a   Yoneda, Masashi ^b  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

^b AICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Amino acid complex; Cirrhosis; Fibrosis; Polaprezinc; Zinc

Indexed keywords

BIOLOGICAL MARKER; CARNOSINE; HYDROXYPROLINE; POLAPREZINC; THIOACETAMIDE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA1; ZINC; ZINC SULFATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE COURSE; HISTOLOGY; LIVER; LIVER CIRRHOSIS; LIVER FIBROSIS; MALE; NONHUMAN; OXIDATIVE STRESS; RAT;

ANIMALS; ANTIOXIDANTS; CARNOSINE; LIVER CIRRHOSIS; MALE; ORGANOMETALLIC COMPOUNDS; OXIDATIVE STRESS; RATS; RATS, WISTAR; THIOACETAMIDE; ZINC; ZINC COMPOUNDS;

RATTUS;

EID: 84855307026     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2011.10.022     Document Type: Article

References (62)

1. Abul H, Mathew TC, Dashti HM, Al-Bader A. Level of superoxide dismutase, glutathione peroxidase and uric acid in thioacetamide-induced cirrhotic rats. Anat Histol Embryol 2002;31:66-71.
2. Arthur MJ, Fibrogenesis II. Metalloproteinases and their inhibitors in liver fibrosis. Am J Physiol Gastrointest Liver Physiol 2000;279:G245-9.
3. Aydin AF, Kusku-Kiraz Z, Dogru-Abbasoglu S, Gulluoglu M, Uysal M, Kocak-Toker N. Effect of carnosine against thioacetamide-induced liver cirrhosis in rat. Peptides 2010;31:67-71.
4. Balkan J, Dogru-Abbasoglu S, Kanbagli O, Cevikbas U, Aykac-Toker G, Uysal M. Taurine has a protective effect against thioacetamide-induced liver cirrhosis by decreasing oxidative stress. Hum Exp Toxicol 2001;20:251-4. (Pubitemid 32684850)
5. Bataller R, Brenner DA. Liver fibrosis. J Clin Invest 2005;115:209-18. (Pubitemid 40385459)
6. Bray TM, Bettger WJ. The physiological role of zinc as an antioxidant. Free Radic Biol Med 1990;8:281-91.
7. Britton RS, Bacon BR. Role of free radicals in liver diseases and hepatic fibrosis. Hepatogastroenterology 1994;41:343-8. (Pubitemid 24273240)
8. Bruck R, Shirin H, Aeed H, Matas Z, Hochman A, Pines M, et al. Prevention of hepatic cirrhosis in rats by hydroxyl radical scavengers. J Hepatol 2001;35:457-64. (Pubitemid 32964444)
9. Capocaccia L, Merli M, Piat C, Servi R, Zullo A, Riggio O. Zinc and other trace elements in liver cirrhosis. Ital J Gastroenterol 1991;23:386-91.
10. Chen WX, Li YM, Yu CH, Cai WM, Zheng M, Chen F. Quantitative analysis of transforming growth factor beta 1 mRNA in patients with alcoholic liver disease. World J Gastroenterol 2002;8:379-81. (Pubitemid 34414901)
11. Chilakapati J, Shankar K, Korrapati MC, Hill RA, Mehendale HM. Saturation toxicokinetics of thioacetamide: role in initiation of liver injury. Drug Metab Dispos 2005;33:1877-85. (Pubitemid 41697274)
12. Chilakapati J, Korrapati MC, Hill RA, Warbritton A, Latendresse JR, Mehendale HM. Toxicokinetics and toxicity of thioacetamide sulfoxide: a metabolite of thioacetamide. Toxicology 2007;230:105-16. (Pubitemid 46111089)
13. Consolo M, Amoroso A, Spandidos DA, Mazzarino MC. Matrix metalloproteinases and their inhibitors as markers of inflammation and fibrosis in chronic liver disease (Review). Int J Mol Med 2009;24:143-52.
14. Cruz A, Padillo FJ, Torres E, Navarrete CM, Munoz-Castaneda JR, Caballero FJ, et al. Melatonin prevents experimental liver cirrhosis induced by thioacetamide in rats. J Pineal Res 2005;39:143-50. (Pubitemid 41140752)
15. Dashti HM, Mathew TC, Jadaon MM, Ashkanani E. Zinc and liver cirrhosis: biochemical and histopathologic assessment. Nutrition 1997;13:206-12. (Pubitemid 27184889)
16. Friedman SL. Liver fibrosis-from bench to bedside. J Hepatol 2003;38(Suppl. 1): S38-53.
17. Gimenez A, Pares A, Alie S, Camps J, Deulofeu R, Caballeria J, et al. Fibrogenic and collagenolytic activity in carbon-tetrachloride-injured rats: beneficial effects of zinc administration. J Hepatol 1994;21:292-8. (Pubitemid 24308749)
18. Gressner AM, Weiskirchen R, Breitkopf K, Dooley S. Roles of TGF-beta in hepatic fibrosis. Front Biosci 2002;7:d793-807.
19. Himoto T, Hosomi N, Nakai S, Deguchi A, Kinekawa F, Matsuki M, et al. Efficacy of zinc administration in patients with hepatitis C virus-related chronic liver disease. Scand J Gastroenterol 2007;42:1078-87. (Pubitemid 47301142)
20. Hipkiss AR, Brownson C. Carnosine reacts with protein carbonyl groups: another possible role for the anti-ageing peptide? Biogerontology 2000;1:217-23.
21. Hsieh CC, Fang HL, Lina WC. Inhibitory effect of Solanum nigrum on thioacetamideinduced liver fibrosis in mice. J Ethnopharmacol 2008;119:117-21.
22. Iredale JP, Benyon RC, Arthur MJ, Ferris WF, Alcolado R, Winwood PJ, et al. Tissue inhibitor of metalloproteinase-1 messenger RNA expression is enhanced relative to interstitial collagenase messenger RNA in experimental liver injury and fibrosis. Hepatology 1996;24:176-84. (Pubitemid 26249431)
23. Kisseleva T, Brenner DA. Mechanisms of fibrogenesis. Exp Biol Med (Maywood) 2008;233:109-22. (Pubitemid 351231543)
24. Kojima-Yuasa A, Ohkita T, Yukami K, Ichikawa H, Takami N, Nakatani T, et al. Involvement of intracellular glutathione in zinc deficiency-induced activation of hepatic stellate cells. Chem Biol Interact 2003;146:89-99. (Pubitemid 36929773)
25. Loguercio C, Federico A. Oxidative stress in viral and alcoholic hepatitis. Free Radic Biol Med 2003;34:1-10. (Pubitemid 36043881)
26. Low TY, Leow CK, Salto-Tellez M, Chung MC. A proteomic analysis of thioacetamide-induced hepatotoxicity and cirrhosis in rat livers. Proteomics 2004;4:3960-74. (Pubitemid 39657471)
27. Marchesini G, Fabbri A, Bianchi G, Brizi M, Zoli M. Zinc supplementation and amino acid-nitrogen metabolism in patients with advanced cirrhosis. Hepatology 1996;23: 1084-92. (Pubitemid 26137051)
28. Matsukura T, Tanaka H. Applicability of zinc complex of L-carnosine for medical use. Biochemistry (Mosc) 2000;65:817-23.
29. Matsuoka S, Matsumura H, Nakamura H, Oshiro S, Arakawa Y, Hayashi J, et al. Zinc supplementation improves the outcome of chronic hepatitis C and liver cirrhosis. J Clin Biochem Nutr 2009;45:292-303.
30. Muller A, Machnik F, Zimmermann T, Schubert H. Thioacetamide-induced cirrhosislike liver lesions in rats-usefulness and reliability of this animal model. Exp Pathol 1988;34:229-36.
31. Murakami Y, Koyabu T, Kawashima A, Kakibuchi N, Kawakami T, Takaguchi K, et al. Zinc supplementation prevents the increase of transaminase in chronic hepatitis C patients during combination therapy with pegylated interferon alpha-2b and ribavirin. J Nutr Sci Vitaminol (Tokyo) 2007;53:213-8. (Pubitemid 47217217)
32. Natarajan SK, Thomas S, Ramamoorthy P, Basivireddy J, Pulimood AB, Ramachandran A, et al. Oxidative stress in the development of liver cirrhosis: a comparison of two different experimental models. J Gastroenterol Hepatol 2006;21:947-57. (Pubitemid 43823277)
33. Odashima M, Otaka M, Jin M, Konishi N, Sato T, Kato S, et al. Induction of a 72-kDa heatshock protein in cultured rat gastric mucosal cells and rat gastric mucosa by zinc Lcarnosine. Dig Dis Sci 2002;47:2799-804. (Pubitemid 35471625)
34. Odashima M, Otaka M, Jin M, Wada I, Horikawa Y, Matsuhashi T, et al. Zinc L-carnosine protects colonic mucosal injury through induction of heat shock protein 72 and suppression of NF-kappaB activation. Life Sci 2006;79:2245-50. (Pubitemid 44666062)
35. Ohkawara T, Takeda H, Kato K, Miyashita K, Kato M, Iwanaga T, et al. Polaprezinc (N-(3-aminopropionyl)-L-histidinato zinc) ameliorates dextran sulfate sodium-induced colitis in mice. Scand J Gastroenterol 2005;40:1321-7. (Pubitemid 41658731)
36. Ohkawara T, Nishihira J, Nagashima R, Takeda H, Asaka M. Polaprezinc protects human colon cells from oxidative injury induced by hydrogen peroxide: relevant to cytoprotective heat shock proteins. World J Gastroenterol 2006;12:6178-81. (Pubitemid 44688168)
37. Pavlica S, Gebhardt R. Comparison of uptake and neuroprotective potential of seven zinc-salts. Neurochem Int 2010;56:84-93.
38. Powell SR. The antioxidant properties of zinc. J Nutr 2000;130:1447S-54S.
39. Prasad AS. Zinc: role in immunity, oxidative stress and chronic inflammation. Curr Opin Clin Nutr Metab Care 2009;12:646-52.
40. Sakaida I, Matsumura Y, Kubota M, Kayano K, Takenaka K, Okita K. The prolyl 4-hydroxylase inhibitor HOE 077 prevents activation of Ito cells, reducing procollagen gene expression in rat liver fibrosis induced by choline-deficient L-amino acid-defined diet. Hepatology 1996;23:755-63. (Pubitemid 26111989)
41. Sakaida I, Uchida K, Matsumura Y, Okita K. Interferon gamma treatment prevents procollagen gene expression without affecting transforming growth factor-beta1 expression in pig serum-induced rat liver fibrosis in vivo. J Hepatol 1998;28:471-9. (Pubitemid 28133552)
42. Salguero Palacios R, Roderfeld M, Hemmann S, Rath T, Atanasova S, Tschuschner A, et al. Activation of hepatic stellate cells is associated with cytokine expression in thioacetamide-induced hepatic fibrosis in mice. Lab Invest 2008;88:1192-203.
43. Samman S, Roberts DC. The effect of zinc supplements on plasma zinc and copper levels and the reported symptoms in healthy volunteers. Med J Aust 1987;146: 246-9. (Pubitemid 17117302)
44. Sano H, Furuta S, Toyama S, Miwa M, Ikeda Y, Suzuki M, et al. Study on the metabolic fate of catena-(S)-[mu-[N alpha-(3- aminopropionyl)histidinato(2-) -N1, N2, O:N tau]-zinc]. 1st communication: absorption, distribution, metabolism and excretion after single administration to rats. Arzneimittelforschung 1991;41:965-75.
45. Sanz N, Diez-Fernandez C, Andres D, Cascales M. Hepatotoxicity and aging: endogenous antioxidant systems in hepatocytes from 2-, 6-, 12-, 18- and 30-month-old rats following a necrogenic dose of thioacetamide. Biochim Biophys Acta 2002;1587:12-20. (Pubitemid 34493829)
46. Seltzer JL, Jeffrey JJ, Eisen AZ. Evidence for mammalian collagenases as zinc ion metalloenzymes. Biochim Biophys Acta 1977;485:179-87. (Pubitemid 8219541)
47. Sidhu P, Garg ML, Dhawan DK. Protective effects of zinc on oxidative stress enzymes in liver of protein-deficient rats. Drug Chem Toxicol 2005;28:211-30. (Pubitemid 40559526)
48. Solis-Herruzo J, De Cuenca B, Munoz-Rivero MC. Intestinal zinc absorption in cirrhotic patients. Z Gastroenterol 1989;27:335-8. (Pubitemid 19182351)
49. Song YM, Chen MD. Zinc supplementation attenuates thioacetamide-induced liver injury and hyperglycemia in mice. Biol Trace Elem Res 2003;92:173-80.
50. Stamoulis I, Kouraklis G, Theocharis S. Zinc and the liver: an active interaction. Dig Dis Sci 2007;52:1595-612. (Pubitemid 46870560)
51. Strnad P, Tao GZ, Zhou Q, Harada M, Toivola DM, Brunt EM, et al. Keratin mutation predisposes to mouse liver fibrosis and unmasks differential effects of the carbon tetrachloride and thioacetamide models. Gastroenterology 2008;134:1169-79. (Pubitemid 351451981)
52. Sugino H, Kumagai N, Watanabe S, Toda K, Takeuchi O, Tsunematsu S, et al. Polaprezinc attenuates liver fibrosis in a mouse model of non-alcoholic steatohepatitis. J Gastroenterol Hepatol 2008;23:1909-16.
53. Sun Y, Oberley LW, Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem 1988;34:497-500.
54. Sun F, Hayami S, Ogiri Y, Haruna S, Tanaka K, Yamada Y, et al. Evaluation of oxidative stress based on lipid hydroperoxide, vitamin C and vitamin E during apoptosis and necrosis caused by thioacetamide in rat liver. Biochim Biophys Acta 2000;1500: 181-5. (Pubitemid 30060390)
55. Takahashi M, Saito H, Higashimoto M, Hibi T. Possible inhibitory effect of oral zinc supplementation on hepatic fibrosis through downregulation of TIMP-1: a pilot study. Hepatol Res 2007;37:405-9. (Pubitemid 46915784)
56. Tsukada S, Parsons CJ, Rippe RA. Mechanisms of liver fibrosis. Clin Chim Acta 2006;364: 33-60. (Pubitemid 43120627)
57. Yamaguchi I, Shibata K, Takei M, Matsuda K. Changes in tissue contents of zinc, copper and iron in rats and beagle dogs treated with polaprezinc. J Toxicol Sci 1996;21: 177-87. (Pubitemid 26341643)
58. Yoshikawa T, Naito Y, Tanigawa T, Yoneta T, Kondo M. The antioxidant properties of a novel zinc-carnosine chelate compound, N-(3-aminopropionyl)-L- histidinato zinc. Biochim Biophys Acta 1991a;1115:15-22.
59. Yoshikawa T, Naito Y, Tanigawa T, Yoneta T, Yasuda M, Ueda S, et al. Effect of zinccarnosine chelate compound (Z-103), a novel antioxidant, on acute gastric mucosal injury induced by ischemia-reperfusion in rats. Free Radic Res Commun 1991b;14:289-96.
60. Zhang Y, Okamura S, Kudo T, Masuo T, Mori M. Calcineurin inhibition by polaprezinc in rats with experimentally-induced colitis. Life Sci 2011;88:432-9.
61. Zhou S, Palmeira CM, Wallace KB. Doxorubicin-induced persistent oxidative stress to cardiac myocytes. Toxicol Lett 2001;121:151-7. (Pubitemid 32441771)
62. Zhou Z, Wang L, Song Z, Saari JT, McClain CJ, Kang YJ. Zinc supplementation prevents alcoholic liver injury in mice through attenuation of oxidative stress. Am J Pathol 2005;166:1681-90. (Pubitemid 40734391)